Physician

Rama Challapalli Sri, M.D.

According to 2025 Medicare claims, Rama Sri, M.D. (NPI: 1891921524) practices nephrology in the Joplin, MO-KS market, with the plurality of this provider's patient population coming from Jasper, MO. This provider's primary affiliated billing organization is FREEMAN-OAK HILL HEALTH SYSTEM (NPI: 1679517023; TIN: 431704371) and primary practice location at 64804-3503. Sri is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Sri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 439 traditional Medicare patients, billed 1,912 HCPCS/CPT codes, and received $165,222 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,246 prescription claims across 411 beneficiaries totaling $293,596 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 75 claims. Open Payments data shows 6 records totaling $202. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $85,893 and ending at $165,222. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $109,295 and ending at $293,596. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$94K$189K2015 Medicare payment: $85,893 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $188,956 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $176,967 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $104,645 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $113,800 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $131,957 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $143,611 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $142,422 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $133,556 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $165,222 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015197540$85,893
20163161,392$188,956
20173661,315$176,967
20184581,539$104,645
20195631,621$113,800
20205521,750$131,957
20214921,596$143,611
20224691,534$142,422
20234511,352$133,556
20244391,912$165,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$320K$639K2015 Drug cost: $109,295 (USD; Tot_Drug_Cst)2016 Drug cost: $492,835 (USD; Tot_Drug_Cst)2017 Drug cost: $639,236 (USD; Tot_Drug_Cst)2018 Drug cost: $100,421 (USD; Tot_Drug_Cst)2019 Drug cost: $50,297 (USD; Tot_Drug_Cst)2020 Drug cost: $95,056 (USD; Tot_Drug_Cst)2021 Drug cost: $161,902 (USD; Tot_Drug_Cst)2022 Drug cost: $130,613 (USD; Tot_Drug_Cst)2023 Drug cost: $248,501 (USD; Tot_Drug_Cst)2024 Drug cost: $293,596 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015122412$109,295
2016146789$492,835
2017170833$639,236
2018190523$100,421
2019226985$50,297
20202711,794$95,056
20212882,094$161,902
20223132,511$130,613
20233192,677$248,501
20244113,246$293,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.7K$3.5K2015 Medicare payment: $3,489 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,248 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,208 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,483 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $575 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,915 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,370 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R53$3,489
2016N/R29$1,248
2017N/R35$1,208
2018N/R52$1,483
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R29$575
2022N/R67$1,915
2023N/RN/RN/R
2024N/R75$1,370

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes7781$123
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more4662$98
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes126559$88
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more252368$65
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's231305$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FarxigaDapagliflozin Propanediol782,954$55,164
JardianceEmpagliflozin592,590$51,102
AuryxiaFerric Citrate14462$28,514
Sevelamer CarbonateSevelamer Carbonate723,129$16,809
VeltassaPatiromer Calcium Sorbitex34804$13,576

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7518Mycophenolic acid, oral, 180 mgNN/R18$518
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R26$314
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R15$282
J7507Tacrolimus, immediate release, oral, 1 mgNN/R16$256

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$202Otsuka America Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rama Challapalli Sri, M.D.?

Tedicare shows public-source Medicare data for Rama Challapalli Sri, M.D. (NPI 1891921524), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rama Challapalli Sri, M.D. have ACO affiliation data?

Rama Challapalli Sri, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616) and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Rama Challapalli Sri, M.D.?

Rama Challapalli Sri, M.D. is linked to FREEMAN-OAK HILL HEALTH SYSTEM (billing NPI 1679517023) in the available physician profile data.

Does Rama Challapalli Sri, M.D. have Open Payments data?

Rama Challapalli Sri, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.